Related Articles
lncRNA TUG1 inhibits the cancer stem cell‑like properties of temozolomide‑resistant glioma cells by interacting with EZH2
Gene expression profiling predicts response to temozolomide in malignant gliomas
Temozolomide in combination with metformin act synergistically to inhibit proliferation and expansion of glioma stem-like cells
Gene expression profiles predicting the response to IFN-β and a combination of temozolomide and IFN-β in malignant gliomas
Acute lymphoblastic leukemia following temozolomide treatment in a patient with glioblastoma: A case report and review of the literature